Flow Traders U.S.’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Flow Traders U.S.’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,247	Closed	-$104K	–	1181
2022 Q4	$104K	Sell	10,247 -1,236	-11%	-$12.6K	0.01%	665
2022 Q3	$116K	Buy	+11,483	New	+$116K	0.01%	801

Other funds holding PBAXU

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Flow Traders U.S.'s PBAXU Position: Q1 2023 in Review

Flow Traders U.S. sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q1 2023, closing a stake of 10,247 shares — an estimated $104K sold.

Flow Traders U.S. first reported a position in PBAXU in Q3 2022 and held it in 2 quarters. The position peaked at $116K in Q3 2022. 2 funds tracked by Wall St. Rank hold PBAXU as of Q1 2023.

Flow Traders U.S. reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
Flow Traders U.S. sold 10,247 Phoenix Biotech Acquisition Corp. Unit shares in Q1 2023, an estimated $104K.
Flow Traders U.S. first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q3 2022 and held it in 2 quarters.
Flow Traders U.S.'s Phoenix Biotech Acquisition Corp. Unit position peaked at $116K in Q3 2022.
2 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q1 2023.

Based on Flow Traders U.S.'s 13F filing for Q1 2023, filed 12 May 2023.